Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram.
Ana Fernández MontesF Vazquez RiveraN Martinez LagoM Covela RúaA Cousillas CastiñeirasP Gonzalez VillarroelJ de la Cámara GómezJ C Méndez MéndezM Salgado FernándezS Candamio FolgarM Reboredo LópezM Carmona CamposE Gallardo MartínM Jorge FernándezM L Pellón AugustoL París BouzasJ García GómezPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2019)
The results of this study confirm the efficacy and safety of trifluridine/tipiracil in chemorefractory mCRC patients. However, patients in clinical practice differ from patients in clinical trials. Due to this, prognostic factors have special importance to offer the best therapeutic approach.